Related Experiment Videos

[Diffusion of ofloxacin in infected ascitic fluid]

J P Latrive1, J C Barbare, J P Darchis

  • 1Service d'Hépatogastroentérologie, Centre Hospitalier de Compiègne, Compiègne.

Pathologie-Biologie
|June 1, 1989
PubMed

Insights

This study evaluated ofloxacin levels in cirrhotic patients with spontaneous bacterial peritonitis. Ofloxacin concentrations in plasma and ascitic fluid suggest its effectiveness in treating this infection.

Area of Science:

  • Pharmacokinetics
  • Infectious Diseases
  • Hepatology

Background:

  • Spontaneous bacterial peritonitis (SBP) is a serious complication of cirrhosis.
  • Effective antibiotic therapy is crucial for managing SBP.

Purpose of the Study:

  • To investigate the diffusion and concentration of ofloxacin in plasma and ascitic fluid of cirrhotic patients with SBP.
  • To assess the potential of ofloxacin for treating SBP.

Main Methods:

  • 13 cirrhotic patients with SBP were enrolled.
  • Plasma and ascitic fluid samples were collected at various time points after oral administration of ofloxacin (200 mg).
  • High-Performance Liquid Chromatography (HPLC) was used to measure ofloxacin concentrations.

Main Results:

  • Plasmatic concentrations ranged from 0 to 3.62 mg/l, and ascitic fluid concentrations ranged from 0 to 1.95 mg/l after the first dose.
  • Steady-state concentrations were found to be higher than the Minimum Inhibitory Concentrations (MICs) for common causative organisms.
  • Comparable drug levels were observed in both plasma and ascitic fluid.

Conclusions:

  • Ofloxacin demonstrates good diffusion into the ascitic fluid.
  • The achieved concentrations suggest that ofloxacin is a promising therapeutic option for spontaneous bacterial peritonitis in cirrhotic patients.

Related Concept Videos